[HTML][HTML] B vitamin polymorphisms and behavior: evidence of associations with neurodevelopment, depression, schizophrenia, bipolar disorder and cognitive decline

ES Mitchell, N Conus, J Kaput - Neuroscience & Biobehavioral Reviews, 2014 - Elsevier
The B vitamins folic acid, vitamin B12 and B6 are essential for neuronal function, and severe
deficiencies have been linked to increased risk of neurodevelopmental disorders …

Classics in chemical neuroscience: aripiprazole

AB Casey, CE Canal - ACS chemical neuroscience, 2017 - ACS Publications
Aripiprazole was the first antipsychotic developed to possess agonist properties at
dopamine D2 autoreceptors, a groundbreaking strategy that presented a new vista for …

DNA methylation and antipsychotic treatment mechanisms in schizophrenia: Progress and future directions

ES Ovenden, NW McGregor, RA Emsley… - Progress in Neuro …, 2018 - Elsevier
Antipsychotic response in schizophrenia is a complex, multifactorial trait influenced by
pharmacogenetic factors. With genetic studies thus far providing little biological insight or …

Meta-analyses of Blood Homocysteine Levels for Gender and Genetic Association Studies of the MTHFR C677T Polymorphism in Schizophrenia

A Nishi, S Numata, A Tajima, M Kinoshita… - Schizophrenia …, 2014 - academic.oup.com
Previous studies suggest that elevated blood homocysteine levels and the
methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism are risk factors for …

Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa

KM Pearson-Fuhrhop, B Minton, D Acevedo… - PloS one, 2013 - journals.plos.org
Dopamine is important to learning and plasticity. Dopaminergic drugs are the focus of many
therapies targeting the motor system, where high inter-individual differences in response are …

The pharmacogenetics of treatment with olanzapine

P Zubiaur, P Soria-Chacartegui… - …, 2021 - Taylor & Francis
Genetic polymorphism in olanzapine-metabolizing enzymes, transporters and drug targets is
associated with alterations in safety and efficacy. The aim of this systematic review is to …

5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders

TA Mestre, M Zurowski, SH Fox - Expert opinion on investigational …, 2013 - Taylor & Francis
Introduction: 5-Hydroxytryptamine 2A receptors (5-HT2A-Rs) are widely expressed in the
brain and have been implicated in mood and behavior. Based on the use of atypical …

Pharmacogenetics in psychiatry

F Corponi, C Fabbri, A Serretti - Advances in Pharmacology, 2018 - Elsevier
Mental illness represents a major health issue both at the individual and at the
socioeconomical level. This is partly due to the current suboptimal treatment options …

Catechol-O-methyltransferase Val158Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizo-affective disorder patients: a …

E Huang, CC Zai, A Lisoway… - International Journal …, 2016 - academic.oup.com
Background: The catechol-O-methyltransferase (COMT) enzyme plays a crucial role in
dopamine degradation, and the COMT Val158Met polymorphism (rs4680) is associated with …

Pharmacogenetics and schizophrenia—can genomics improve the treatment with second-generation antipsychotics?

O Płaza, P Gałecki, A Orzechowska, M Gałecka… - Biomedicines, 2022 - mdpi.com
Schizophrenia (SCZ) is a complex psychiatric disorder of multifactorial origin, in which both
genetic and environmental factors have an impact on its onset, course, and outcome. Large …